Nymox Pharmaceuticals (NYMX) Covered Calls

Nymox Pharmaceuticals covered calls Nymox Pharmaceutical Corporation is a biopharmaceutical company, which is engaged in the research and development of diagnostics and drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease.

You can sell covered calls on Nymox Pharmaceuticals to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NYMX (prices last updated Tue 4:16 PM ET):

Nymox Pharmaceuticals (NYMX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.44 -0.16 1.39 2.20 129K - 0.0B
Covered Calls For Nymox Pharmaceuticals (NYMX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 1 0.30 1.90 -47.4% -4325.3%
Jan 18 1 0.35 1.85 -45.9% -523.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which specializes in the research and development of products for the aging population. Currently, it markets NicAlertTM and TobacAlertTM, tests that use urine or saliva to detect use of tobacco products. The company develops NX-1207, a novel treatment for benign prostatic hyperplasia, which is in Phase 3 clinical trials. It also has pipeline drug candidates aimed at the causes of Alzheimer's disease and new treatments of bacterial infections in humans. Nymox Pharmaceutical was founded by Paul Averback on May 30, 1995 and is headquartered in St.-Laurent, Canada.